Cost of peritoneal dialysis and haemodialysis across the world

Peritoneal dialysis (PD) as a modality is underutilized in most parts of the world today despite several advantages including the possibility of it being offered in the remotest of locations and being significantly more affordable than haemodialysis (HD) in most cases. In this article, we will compa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nephrology, dialysis, transplantation Ročník 28; číslo 10; s. 2553
Hlavní autoři: Karopadi, Akash Nayak, Mason, Giacomo, Rettore, Enrico, Ronco, Claudio
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.10.2013
Témata:
Cost-Benefit Analysis
Global Health - economics
Humans
Kidney Diseases - economics
Kidney Diseases - therapy
Peritoneal Dialysis - economics
Prognosis
Renal Dialysis - economics
haemodialysis
continuous ambulatory peritoneal dialysis (capd)
peritoneal dialysis
economic analysis
economic impact
ISSN:1460-2385, 1460-2385
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Peritoneal dialysis (PD) as a modality is underutilized in most parts of the world today despite several advantages including the possibility of it being offered in the remotest of locations and being significantly more affordable than haemodialysis (HD) in most cases. In this article, we will compare the cost of HD and PD in several countries to demonstrate that PD is less than, or at least as expensive as, HD. A thorough literature survey of EMBASE and PUBMED was conducted; 78 articles which compared the annual PD and annual HD costs were finally selected. Careful attention was paid to the methodology followed by each study and the year it was published in. Our final calculations included 46 countries (20 developed and 26 developing). We found that the cost of HD was between 1.25 and 2.35 times the cost of PD in 22 countries (17 developed and 5 developing), between 0.90 and 1.25 times the cost of PD in 15 countries (2 developed and 13 developing), and between 0.22 and 0.90 times the cost of PD in 9 countries (1 developed and 8 developing). From our analysis, it is evident that most developed countries can provide PD at a lesser expense to the healthcare system than HD. The evidence on developing countries is more mixed, but in most cases PD can be provided at a similar cost where economies of scale have been achieved, either by local production or by low import duties on PD equipment.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1460-2385
1460-2385
DOI:10.1093/ndt/gft214